Clear Street Launches Healthcare & Biotechnology Equity Research

BusinesswireDec 17 14:00 ET

Bristol Myers Squibb Terminates Agreements With Immatics Due To Ongoing Portfolio Prioritization Efforts Within BMS For Allogeneic Programs; Collaboration With BMS Under The 2019 Multi-Target TCR-T Strategic Collaboration Agreement Remains Ongoing

BenzingaDec 16 09:42 ET

Mizuho Securities Maintains Immatics(IMTX.US) With Buy Rating, Maintains Target Price $16

Moomoo NewsDec 16 06:31 ET · Ratings

Mizuho Securities Sticks to Its Buy Rating for Immatics (IMTX)

TipRanksDec 16 05:55 ET · Ratings

Immatics N.V. Reports Strong Q3 2024 Progress and Financials

TipRanksNov 25 22:57 ET

Goldman Sachs Initiates Immatics(IMTX.US) With Buy Rating, Announces Target Price $13.5

Moomoo NewsNov 25 17:31 ET · Ratings